H.C. Wainwright Starts Ocera Therapeutics (OCRX) at Buy, $10 PT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Ocera Therapeutics (OCRX) Surges in Pre-Open Trade Amid New 'Buy' Rating
December 28, 2016 8:29 AM ESTOcera Therapeutics (NASDAQ: OCRX) shares are surging 25% in pre-open trade as the key off a new Buy rating and $10 price target from H.C. Wainwright. Shares last traded at $2.75,
... More